Allscripts (MDRX) Reports In-Line Q2 EPS; Boosts Bottom-End of FY11 Outlook
Allscripts-Misys Healthcare (NASDAQ: MDRX) reported Q2 EPS of $0.22, in-line with the analyst estimate of $0.22. Revenue for the quarter came in at $363.5 million versus the consensus estimate of $355.76 million.
Allscripts-Misys Healthcare sees FY2011 EPS of $0.88-$0.90, versus prior guidance of $0.86-$0.90 and the consensus of $0.90. Allscripts-Misys Healthcare sees FY2011 revenue of $1440-$1.450 million, versus prior guidance of $1.425-$1.450 million and the consensus of $1.44 million.
Allscripts-Misys Healthcare sees FY2011 EPS of $0.88-$0.90, versus prior guidance of $0.86-$0.90 and the consensus of $0.90. Allscripts-Misys Healthcare sees FY2011 revenue of $1440-$1.450 million, versus prior guidance of $1.425-$1.450 million and the consensus of $1.44 million.